Introduction: Platelets participate in inflammatory disorders through a variety of different functional responses, including chemotaxis, platelet-leukocyte complex formation and facilitation of leukocyte recruitment that are thought to be distinct from platelet aggregation. This may account for why classical anti-platelet drugs have failed to ameliorate inflammatory disorders where platelets are known to participate, suggesting that distinct pathways may control inflammatory and haemostatic functions of platelets. In the present study, we have therefore investigated the effect of different stimuli on several different functions of platelets preferentially involved either in haemostasis or in inflammation.
The central role of platelets in haemostasis is widely established and takes place through a series of specialized functions of this cell type. Under flow conditions at sites of vascular damage platelets become exposed to subendothelial-bound von-Willebrand factor (VWF) and collagen. This induces platelet adhesion and activation which triggers further platelet recruitment, and platelet-platelet interactions through the secretion of platelet agonists, including ADP, and the synthesis and release of thromboxane A 2 (TxA 2 ) [1] . However, platelet activation also occurs in a range of inflammatory and auto-immune disorders, including rheumatoid arthritis [2] , osteoarthritis [3] , and airway diseases such as asthma [4, 5] , acute lung injury (ALI), acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD) [6] , although not necessarily involving classical platelet aggregation or secretion. In animal models evidence has been provided for a critical role of platelets in the recruitment of leukocytes to inflamed tissues in response to allergic and non-allergic inflammatory insults [7] [8] [9] [10] . Additional evidence of platelet activation in inflammatory disorders is supported by the detection of circulating platelet-leukocyte complexes in patients with allergic asthma during allergen-triggered airways obstruction, coupled with increased blood levels of the platelet-derived pro-inflammatory mediators β-thromboglobulin (β-TG), platelet activating factor (PAF), platelet factor 4 (PF-4) and RANTES [11, 12] . Platelets have also been shown to migrate towards inflammatory stimuli, both in vitro and in vivo [13] [14] [15] [16] . However, platelets that had migrated extravascularly into tissues did not show the ultrastructural features of activation and degranulation, suggesting that classical platelet activation is not required for platelet migration [17] .
Moreover, platelet migration in response to allergen in sensitized mice and humans is mediated by the binding of allergen-bound IgE to contiguous FcεRI receptors inducing their cross-linking, a phenomenon previously shown to trigger other inflammatory platelet responses, such as cytotoxicity due to the release of oxygen free radicals [18] and chemokine release [19] .
Whilst the mechanisms of platelet activation in response to inflammatory stimuli remain poorly defined, recent research has highlighted the role of the small Rho GTPase RhoA and Rac-GEFs (P-
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haemostasis [9, 20] . Furthermore, distinct non-canonical (RhoA, Rac-1) signalling events downstream of platelet P2Y 1 receptor activation by ADP have been shown to control platelet motility, and interactions with neutrophils, in contrast to ADP-induced aggregation and the canonical P2Y 1 receptor PLC signalling cascade [21] . This functional selectivity in signalling reveals the importance of different molecular signalling pathways of platelet activation during functional activities pertinent to inflammation compared to haemostasis [21] . Stimulation of platelets with either inflammatory or haemostatic stimuli also appears to induce different patterns of phosphorylation of intracellular signalling kinases, including Akt, ERK1, ERK2 and p38 [22] .
Moreover, platelets have been shown to be critical in the progression of inflammation in experimental models of arthritis by mechanisms independent from thromboxane and ADP receptors, and from aggregation, suggesting that the pathways involved may be distinct [2] .
Platelets contain a range of biologically-active molecules in their α-granules and recent evidence suggests that different subsets of α-granules, differentially released depending on the stimulus, are present in platelets [23] . In vivo studies have also supported the hypothesis that the proinflammatory role of platelets is distinct from the role of platelets in haemostasis, as plateletdependent inflammatory cell recruitment may be inhibited by drugs not influencing platelet aggregation [9, 10] .
These observations, describing a divergence in platelet functions, support the hypothesis of the existence of a dichotomy in platelet activation originally proposed by one of us nearly two decades ago [24] , with the triggering of different platelet functions depending on the inflammatory versus haemostatic nature of the stimulus. 
Materials and Methods
Detailed material and methods pertaining to the measurement of platelet-granulocyte, and plateletmonocyte complex formation, and platelet ultrapurification are described in the online supplementary methods.
Platelet preparation.
Platelets were isolated from peripheral blood collected from human healthy volunteers who had not taken nonsteroidal anti-inflammatory drugs (NSAIDs) or other drug classes known to influence platelet function in the previous seven days, and who did not suffer from allergic disorders. For all studies blood was collected in accordance with local ethical approval and adhered to regulations outlined by the UK Human Tissue Act, 2004.
Citrated venous blood was centrifuged at 160g for 10 minutes at room temperature to obtain platelet rich plasma (PRP). Platelets were then isolated by gel-filtration or washed using Mustard's method, as previously described [25] .
Haemostatic and inflammatory stimuli. Table 1 shows a summary of the receptors involved in the platelet responses to the various tested stimuli.
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Measurement of platelet functions.
Platelet aggregation
Washed platelets were incubated with 2mg/ml fibrinogen and then stimulated with either haemostatic or inflammatory agonists, or the respective vehicle controls for 10 minutes.
Aggregation was measured by light transmission aggregometry (LTA) using a Bio/Data
Corporation optical aggregometer, as previously described [35] , and reported as maximal amplitude (%).
Platelet-leukocyte complex formation
Citrated whole blood was stimulated with either haemostatic or inflammatory agonists, or the respective vehicle controls, for 30 minutes under continuous gentle mixing on a rotating platform (Rotatest Shaker R100, Ludcham, Speed setting 3.5). Thereafter, samples were incubated with saturating concentrations of the platelet specific anti-CD41 FITC-labelled antibody, and the leukocyte specific anti-CD45 PC5-labelled antibody, or isotype control antibodies (all from Beckman Coulter, Miami, FL, USA), and then a hypotonic buffer was added to lyse erythrocytes.
Events staining positive for both CD45 and CD41 were considered to represent platelet-leukocyte complexes and quantified by flow cytometry (FC 500, Beckman Coulter, Miami, Florida, USA).
Results are expressed as fold increase of the percentage of positive cells compared to the vehicle [36] .
Platelet migration
Platelet migration was assessed using transwell inserts (BD Falcon, Bedford, MA, USA) with 3.0 μm pore size membranes. Either haemostatic or inflammatory agonists were added to the lower compartment volumes followed as per manufacturer's instructions, while washed platelets (2x10 7 /ml), isolated from ACD-anticoagulated human venous blood, were placed in the upper compartment. Chambers were then kept in a humidified atmosphere (5% CO 2 , pH 7.4, 37°C) for 90 minutes, as previously reported [21] . Migrated platelets positively stained for CD41 were then counted by flow cytometry using Flow-Count fluorospheres (Beckman Coulter, Miami, FL, USA).
A C C E P T E D M A N U S C R I P T
response to a specific stimulus divided by the number of platelets migrated in response to the medium [14] .
Platelet protein tyrosine phosphorylation
Washed platelets were stimulated for 15 sec, 2 and15 min) with either haemostatic or inflammatory stimuli. Samples were then lysed with Tris-HCl (40mM), NaCl (0.3M), EDTA (1mM), Na 3 
Results
Haemostatic, but not inflammatory, stimuli induce platelet aggregation.
The aim of this study was to compare platelet responses to haemostatic versus inflammatory agonists, to examine if a different platelet response exists depending on the kind of stimulation. To test the functional effects of haemostatic versus inflammatory stimulation, we performed aggregation studies with washed platelets. After 10 minutes, all haemostatic stimuli tested (ADP, Coll, CVX, Epi, TRAP-6 and U46619) elicited concentration-dependent, and significant, platelet aggregation, with a variable extent depending on the stimulus (Figure 1A) . ADP 0. In contrast, none of the inflammatory stimuli (fMLP, Hist, IL-1β, LPS, MDC, SDF-1α, and 5-HT)
induced platelet aggregation (Figure 1B) .
Haemostatic and some inflammatory stimuli induce platelet-leukocyte complexes formation.
To further investigate the differences in platelet response depending if their stimulation was induced with haemostatic or inflammatory agonists, we measured platelet-leukocyte complex formation in whole blood. All the haemostatic platelet agonists induced a significant increase in the percentage of platelet-leukocyte complexes formed in human whole blood compared to vehicle, (Figure 2A) .
However, some of the inflammatory stimuli (fMLP, SDF-1α and 5-HT) also induced a concentration-dependent increase in the formation of platelet-leukocyte complexes in human whole blood, although to a much lesser extent compared to haemostatic stimuli (Figure 2B) . Other inflammatory stimuli, for example IL-1β, and LPS, increased the formation of platelet-leukocyte
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T 14 complexes, although this was only observed at the lowest concentrations tested (0.1µg/ml IL-1β, 0.1ng/ml LPS) ( Figure 2B) .
We then chose a haemostatic and an inflammatory platelet agonist, ADP and fMLP respectively, and we assessed platelet-granulocyte and platelet-monocyte complex formation to identify the different leukocyte subtypes involved. Stimulation of whole blood with ADP 10µM induced platelet interaction with both granulocytes and monocytes (Supplemental figure 1A) . In contrast, fMLP essentially involved the granulocytes only. fMLP induced a strong significant increase of plateletgranulocyte complex formation at all the three tested concentrations, while it stimulated weakly and not significantly platelet-monocyte complex formation (Supplemental figure 1B) . Furthermore, whilst the fold change in platelet-leukocyte complex formation for inflammatory agonists was generally less than that of haemostatic agonists (Figure 2A and 2B) , it was apparent that the fold change in platelet-neutrophil complex formation in response to fMLP was considerably greater than that of ADP (Supplementary figure 1A and 1B) .
Inflammatory stimuli, but not haemostatic stimuli, induce platelet migration.
A less recognised platelet function, that is one of the crucial functions of "bona fide" inflammatory cells, is their ability to undergo chemotaxis both in vitro and migrate into inflammed tissue, in several inflammatory conditions. Thus, we assessed if all the platelet agonists tested were able to stimulate platelet chemotaxis, using the transwell insert system. Several of the tested inflammatory stimuli (fMLP, LPS, MDC, and SDF-1α) induced human platelet migration (Figure 3B) . In contrast, no platelet migration was observed towards the remaining inflammatory stimuli tested (Hist, IL-1β and 5-HT) (Figure 3B) , or towards any of the haemostatic platelet agonists tested ( Figure 3A) . In order to be sure that any leukocyte contamination of washed platelet suspensions did not influence the platelet migration assay, we compared the chemotactic index of platelets towards fMLP obtained with purification using the classical Mustard's washing procedure with the
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was invariably <0.005% (0.0021±0,0005%), yielding a degree of purity sufficient to permit a reliable interpretation of results as of exclusive platelet origin. No significant differences were reported comparing the two different platelet preparations (Supplemental figure 2A,B) .
Haemostatic or inflammatory stimuli induce differential tyrosine phosphorylation in platelets.
To elucidate whether haemostatic and inflammatory stimuli triggered different signaling pathways downstream of their respective receptors, we examined the platelet protein phosphorylation kinetics for up to 15 minutes. Platelet activation with haemostatic stimuli induced a rapid increase in total tyrosine phosphorylation, already after 15 seconds of stimulation, that reached a plateau at 2 minutes, and had decreased at 15 minutes (Figure 4A ). Platelet activation with inflammatory stimuli instead induced a much milder increase in total tyrosine phosphorylation after 15 seconds of stimulation, followed by either a decrease (MDC and fMLP), or by a late increase (SDF-1α and LPS) ( Figure 4B ). Qualitative differences in total Tyr-phosphorylation patterns following platelet stimulation with collagen, as thrombotic stimulus, and SDF-1α, as inflammatory stimulus, are shown in Supplemental figure 3. A much more rapid and intense increase in total tyrosine phosphorylation is evident with a thrombotic stimulus (collagen) compared to that obtained with an inflammatory stimulus (SDF-1α), and platelet stimulation with collagen, but not with SDF-1α, induces the phosphorylation of proteins with the highest and the lowest molecular weight (Supplemental figure 3) .
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Discussion
This study was conducted to further investigate whether platelets have a different functional response depending on the nature of the activating stimuli, either haemostatic or inflammatory.
Our results support the existance of a dichotomy in platelet function, confirming a hypothesis previously formulated [24] . Using three different in vitro platelet function assays exploring the haemostatic and inflammatory activities of platelets we observed clear differences in the triggered platelet functions depending on the nature of the activating stimuli. In fact, most inflammatory stimuli induced platelet chemotaxis, but none of them was able to elicit platelet aggregation, whilst all the haemostatic stimuli induced platelet aggregation, without stimulating platelet chemotaxis. On the other hand, both haemostatic and inflammatory stimuli stimulated the formation of plateletleukocyte complexes in whole blood, although to differing extents: the haemostatic agonists induced a stronger heterotypic interaction between platelets and leukocytes, compared to inflammatory stimuli (all the results are summarized in Table 2 ). ADP, TRAP-6 and U46619 act on 7-transmembrane G-protein-coupled receptors (7TM-GPCRs) coupled to a range of different signalling cascades. The platelet purinergic ADP receptors P2Y 1 and P2Y 12 are associated with G q and G i/2 , respectively, whilst PAR-1, activated by TRAP-6, is linked to G q , G i/z and G 12/13 , and TP, activated by U46619, to the G q and G 12/13 signalling pathways, inducing platelet shape change, α IIb β 3 activation and granule release. The release of further platelet agonists stored within platelet granules results in the amplification of platelet activation contributing to α IIb β 3 integrin activation and platelet aggregation [1] . Epinephrine, however, triggered only weak platelet activation, in agreement with previous literature where it was described either as a weak platelet activating stimulus, or as a platelet primer [38, 39] . Collagen, acting through the GPVI and α 2 β 1 receptors, and convulxin, acting as a selective GPVI agonist, induced platelet aggregation, and the formation of plateletleukocyte complexes. The reported functional platelet responses are compatible with both collagen and convulxin activating the ITAM GPVI receptor. Indeed, the selective α 2 β 1 agonist, GFOGER, has been reported to be incapable of inducing platelet aggregation, but to be able to induce platelet
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previous observations describing this protein as a strong platelet stimulus [42] .
Whilst all of the tested haemostatic agonists induced aggregation, and platelet-leukocyte complex formation, none of the haemostatic stimuli was able to induce platelet chemotaxis, a typical inflammatory function of platelets [16] . In contrast, chemotaxis was triggered by most of the inflammatory stimuli (fMLP, LPS, MDC and SDF-1α). These findings are in agreement with previous results showing in vitro platelet chemotaxis elicited by fMLP [13] and SDF-1α [15] , and platelet recruitment to the lung and liver induced by LPS in vivo [16, 43] . On the other hand, none of the tested inflammatory stimuli induced platelet aggregation, whilst fMLP, SDF-1α and 5-HT induced a significant, albeit modest, increase in the formation of platelet-leukocyte complexes in whole blood, in agreement with previous data [44] [45] [46] . Although stimulation of whole blood with these mediators might lead to leukocyte activation independently from platelet activation, these data are in agreement with previous observations showing that platelet stimulation with non-aggregatory stimuli can directly lead to the formation of platelet-neutrophil complexes [47] . IL-1β and LPS induced the formation of platelet-leukocyte complexes; however, there was no concentrationdependent relationship, with effects observed at the lowest concentrations tested. It remains to be understood the dynamics by which platelets might be stimulated by these two inflammatory mediators.
We have previously shown that platelet-induced neutrophil chemotaxis towards MDC is dependent on the simultaneous presence of ADP, and ADP has also been implicated as a co-agonist alongside chemokines in leukocyte activation and adhesion molecule expression [9, 21, 39] . This may suggest that platelet-leukocyte complex formation may either be involved in priming platelets, allowing the subsequent potentiation of certain functional responses [48] , or that these interactions require the concomitant stimulation of ADP receptors alongside chemokine receptors. Whilst for simplicity, we have categorised ADP as an agonist of haemostasis here, it is recognised that ADP, and other nucleotides are important danger-associated molecular patterns (DAMPs) that are generated upon
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18 trauma, where both haemostatic pathways and host defence are required [48] . Indeed, we and others have shown the requirement for some agents, including ADP, as a primer [39] necessary for robust platelet migration towards fMLP [21] , and platelet-induced neutrophil chemotaxis towards MDC [9, 21] . Further research is therefore warranted to investigate whether co-stimulation of platelets with low dose ADP and other inflammatory stimuli leads to potentiation of chemokine-induced platelet transmigration or other functions associated with inflammation.
The differences we observed in platelet functional responses to haemostatic and inflammatory stimuli are associated with differences in the degree and kinetics of platelet protein phosphorylation.
Although the main aim of our study was that of exploring the existence of a possible dichotomy in platelet functional responses to haemostatic and inflammatory stimuli, and not to investigate the signal transduction pathways associated with these functional responses, we observed a peak in tyrosine phosphorylation at 2 minutes post stimulation with the haemostatic stimuli whilst in contrast we observed a peak phosphorylation within 15 seconds in response to the inflammatory stimuli. Differences in the kinetics of platelet Akt, ERK1/2 and p38 phosphorylation in response to thrombin and to the inflammatory TLR2/1 receptor agonist lipopeptide Pam3CSK4 have been previously reported [22] . Moreover, we have previously shown that ADP stimulation triggering inflammatory events (pulmonary leukocyte recruitment) acts through activating the P2Y 1 receptors and small Rho GTPases Rac1 and RhoA [9, 10] , whilst it acts through the classical PLC pathway when triggering haemostatic responses, possibly as a result of differential molecular docking of endogenous agonists to the receptor [21] . However, those studies demonstrated the different signalling pathways induced by a single agonist leading to different platelet functional responses, and did not investigate the effect of different platelet stimuli on platelet responses. Deeper investigations on the signalling pathways activated by haemostatic or inflammatory stimuli, will be the subject of further studies and will potentially lead to the identification of new targets for blocking inflammatory functions of platelets without affecting the "classical" role of platelets in haemostasis.
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Although, classical anti-platelet drugs have failed to demonstrate any therapeutic benefit in patients with allergic or inflammatory disorders [2, 5, [49] [50] [51] , the development of anti-inflammatory therapies targeting specific inflammatory functions of platelets remains an attractive therapeutic avenue. A better definition of the receptors and signalling pathways involved in the triggering of the inflammatory rather than the haemostatic functions of platelets, may indeed lead to the development of novel therapeutic strategies.
Conclusions
The current results provide evidence for a different functional response of platelets towards haemostatic versus inflammatory stimuli supporting the existence of a dichotomy in platelet function between haemostasis and inflammation, summarized in Figure 5 . A deep understanding of the biochemical pathways behind these different functional responses may lead to the identification of novel therapeutic targets for inflammatory disorders not compromising the haemostatic functions of platelets. Table 2 Agonist 
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